SI1586320T1 - Citizin vsebujoäś trdne dozirne oblike - Google Patents

Citizin vsebujoäś trdne dozirne oblike

Info

Publication number
SI1586320T1
SI1586320T1 SI200530386T SI200530386T SI1586320T1 SI 1586320 T1 SI1586320 T1 SI 1586320T1 SI 200530386 T SI200530386 T SI 200530386T SI 200530386 T SI200530386 T SI 200530386T SI 1586320 T1 SI1586320 T1 SI 1586320T1
Authority
SI
Slovenia
Prior art keywords
cytisine
dosage form
solid dosage
containing solid
tablets
Prior art date
Application number
SI200530386T
Other languages
English (en)
Inventor
Vesselin Evgeniev Daskalov
Angel Radoslavov Timchev
Violeta Andreeva Pavlova
Radka Kostova Grozdeva
Vlayko Petrov Tonev
Yanka Ivanova Borissova
Dobrina Hristova Dobreva
Todorka Boncheva Bendurska
Original Assignee
Sopharma Ad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sopharma Ad filed Critical Sopharma Ad
Publication of SI1586320T1 publication Critical patent/SI1586320T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200530386T 2004-04-16 2005-02-02 Citizin vsebujoäś trdne dozirne oblike SI1586320T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BG108686A BG65536B1 (bg) 2004-04-16 2004-04-16 Лекарствена форма, съдържаща цитизин
EP05472001A EP1586320B1 (en) 2004-04-16 2005-02-02 Cytisine containing solid dosage form

Publications (1)

Publication Number Publication Date
SI1586320T1 true SI1586320T1 (sl) 2009-02-28

Family

ID=34943361

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530386T SI1586320T1 (sl) 2004-04-16 2005-02-02 Citizin vsebujoäś trdne dozirne oblike

Country Status (6)

Country Link
EP (1) EP1586320B1 (sl)
AT (1) ATE401075T1 (sl)
BG (1) BG65536B1 (sl)
DE (1) DE602005008128D1 (sl)
PL (1) PL1586320T3 (sl)
SI (1) SI1586320T1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL220354B1 (pl) 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania
CN103284319A (zh) * 2013-06-20 2013-09-11 昌宁德康生物科技有限公司 一种金雀花碱替代尼古丁口腔雾化液及其制备方法
PL408608A1 (pl) 2014-06-18 2015-12-21 Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
GB201602145D0 (en) * 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
AU2017313390A1 (en) 2016-08-19 2019-03-07 The University Of Bristol Cytisine derivatives for the treatment of addiction
JP7178158B2 (ja) 2017-07-24 2022-11-25 アチーブ ファーマ ユーケイ リミテッド シチシン塩、シチシン塩の溶媒和物または水和物、シチシン塩の製造方法、医薬組成物、および治療方法
EP3598968A1 (en) 2018-07-23 2020-01-29 Adamed Pharma S.A. Solid pharmaceutical cytisine composition
BG67408B1 (bg) 2019-04-12 2022-01-17 Софарма Ад Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977131A (en) * 1997-04-09 1999-11-02 Pfizer Inc. Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
EP1178045B1 (en) * 1997-04-09 2003-05-28 Pfizer Inc. Azaindole-ethylamine derivatives as nicotine acetylchlorine receptor binding agents

Also Published As

Publication number Publication date
BG65536B1 (bg) 2008-11-28
DE602005008128D1 (de) 2008-08-28
PL1586320T3 (pl) 2008-12-31
EP1586320A1 (en) 2005-10-19
BG108686A (en) 2005-12-30
EP1586320B1 (en) 2008-07-16
ATE401075T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
SI1586320T1 (sl) Citizin vsebujoäś trdne dozirne oblike
UA108594C2 (uk) Одинична дозована фармацевтична форма
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
MY139913A (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
IL181382A0 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
HK1096034A1 (en) A solid dosage form comprising a fibrate
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
AP2003002763A0 (en) Controlled release formulations for oral administration
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
WO2006020522A3 (en) Multiplex drug delivery device
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
IL150528A0 (en) Ibuprofen containing active agent preparation
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
ZA200506992B (en) Fibrate tablet and method for the production thereof
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO2005082331A3 (en) Extended release tablets of clarithromycin
WO2004014318A3 (en) Levothyroxine compositions and methods
MY141008A (en) Oral formulations of deoxypeganine and their uses
WO2003013441A3 (en) Levothyroxine compositions and methods
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
WO2008147245A3 (fr) Composition pharmaceutique de proxodolol à libération contrôlée